Sources: 12Gene Ontology See all sources |
Cellular components related to keratitis according to GeneDecks:| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | membrane raft | GO:045121 | 8.6 | EGFR, TNF, GJA1, CAV1, FAS, CD4 | | 2 | external side of plasma membrane | GO:009897 | 8.6 | ROBO4, CXCL9, THBS1, TLR4, TLR2, TNF | | 3 | cell surface | GO:009986 | 8.1 | TNF, TNFSF4, PTPRJ, HBEGF, TLR2, CAV1 | | 4 | extracellular region | GO:005576 | 5.9 | LTF, NGF, COL9A1, IFNA2, CCL20, CCL2 | | 5 | extracellular space | GO:005615 | 4.8 | CXCL9, IFNA2, ICAM1, HSPD1, AIMP1, TNF | | 6 | integral to plasma membrane | GO:005887 | INF | HLA-DPA1, HLA-DRA, TNF, TNFSF4, PTPRJ, HBEGF |
Biological processes related to keratitis according to GeneDecks: (show top 50)
(show all 85)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | positive regulation of interleukin-12 production | GO:032735 | 10.6 | HSPD1, TNFSF4, TLR2, TLR4, TLR9 | | 2 | positive regulation of nitric-oxide synthase biosynthetic process | GO:051770 | 10.6 | TLR2, TLR4, CCL2, TLR9 | | 3 | positive regulation of inflammatory response | GO:050729 | 10.6 | TLR4, TLR2, TNFSF4, IL18, STAT5B, TLR9 | | 4 | positive regulation of tumor necrosis factor production | GO:032760 | 10.5 | MYD88, IL18, TLR2, TLR4, TLR9 | | 5 | defense response to bacterium | GO:042742 | 10.4 | S100A12, HAMP, LTF, DEFB4A, CCL20, TLR9 | | 6 | positive regulation of interleukin-8 production | GO:032757 | 10.3 | IL18, TLR2, IL1B, TLR4, TLR9 | | 7 | interferon-gamma-mediated signaling pathway | GO:060333 | 10.3 | HLA-B, HLA-DRA, CIITA, ICAM1, CD44, STAT1 | | 8 | response to progesterone stimulus | GO:032570 | 10.3 | TSPO, THBS1, TLR4, CAV1, CCL2 | | 9 | chemotaxis | GO:006935 | 10.2 | CXCL9, CXCL2, CXCL1, DEFB4A, S100A8, CCL2 | | 10 | positive regulation of chemokine production | GO:032722 | 9.9 | TLR2, TLR4, TLR9, TNF, IL6, IL18 | | 11 | positive regulation of interleukin-2 biosynthetic process | GO:045086 | 9.9 | STAT5B, IL1B, IL1A, CD4 | | 12 | positive regulation of peptidyl-tyrosine phosphorylation | GO:050731 | 9.8 | IL6, TLR4, MIF, CD44, CD4, VEGFA | | 13 | cellular response to lipopolysaccharide | GO:071222 | 9.8 | ICAM1, TLR4, IL8, TNFSF4, TSPO, CCL2 | | 14 | cellular response to mechanical stimulus | GO:071260 | 9.8 | NFKB1, IL1B, FAS, MYD88, IL18, TLR8 | | 15 | cell-cell signaling | GO:007267 | 9.7 | CCL20, IFNA2, IL1B, FASLG, IL18, IL17A | | 16 | MyD88-dependent toll-like receptor signaling pathway | GO:002755 | 9.7 | TLR10, RELA, TLR4, HSPD1, MYD88, JUN | | 17 | defense response to Gram-positive bacterium | GO:050830 | 9.7 | IL6, MYD88, MBL2, TLR2, TNF | | 18 | positive regulation of NF-kappaB import into nucleus | GO:042346 | 9.7 | IL1B, TNF, TLR2, TLR9, TLR4 | | 19 | response to radiation | GO:009314 | 9.6 | MMP9, NGF, MBD4, IL18, JUN | | 20 | toll-like receptor 1 signaling pathway | GO:034130 | 9.5 | RELA, MYD88, JUN, NFKB1, TLR2, TLR4 | | 21 | positive regulation of gene expression | GO:010628 | 9.4 | CD44, VEGFA, VDR, PAX6, IL18, GJA1 | | 22 | innate immune response | GO:045087 | 9.4 | TLR10, TLR8, RELA, MBL2, CCR6, IFNA2 | | 23 | positive regulation of interferon-gamma production | GO:032729 | 9.4 | TNFSF4, TNF, TLR4, IL18, HSPD1, IL1B | | 24 | positive regulation of JNK cascade | GO:046330 | 9.3 | IL1A, TLR9, MYD88, TLR4, TNF, IL1B | | 25 | cell surface receptor signaling pathway | GO:007166 | 9.3 | CCL2, IL2RA, MYD88, CD4, MIF, IL17RA | | 26 | positive regulation of peptidyl-serine phosphorylation | GO:033138 | 9.3 | IL6, MIF, VEGFA, CAV1, TNF, CD44 | | 27 | negative regulation of growth of symbiont in host | GO:044130 | 9.3 | MYD88, TLR2, TNF, MBL2 | | 28 | positive regulation of interleukin-6 production | GO:032755 | 9.2 | TNFSF4, HSPD1, TLR4, TLR9, IL6, IL1B | | 29 | positive regulation of smooth muscle cell proliferation | GO:048661 | 9.2 | IL6, HBEGF, MYD88, JUN, TNF, STAT5B | | 30 | lipopolysaccharide-mediated signaling pathway | GO:031663 | 9.2 | TLR4, TNF, CCL2, IL1B, IL18, MYD88 | | 31 | cellular response to interleukin-1 | GO:071347 | 9.2 | NFKB1, ICAM1, CCL2, IL8, IL17A, MMP9 | | 32 | response to glucocorticoid stimulus | GO:051384 | 9.1 | TAT, NGF, TNF, CAV1, CCL2, FAS | | 33 | positive regulation of ERK1 and ERK2 cascade | GO:070374 | 9.1 | IL1B, IL1A, TLR4, TNF, CD44, MIF | | 34 | positive regulation of nitric oxide biosynthetic process | GO:045429 | 9.1 | IL1B, TLR4, TNF, TLR2, EGFR, ICAM1 | | 35 | cytokine-mediated signaling pathway | GO:019221 | 9.1 | IL1B, IL6, STAT5B, STAT1, HLA-DRA, HLA-DPA1 | | 36 | response to lipopolysaccharide | GO:032496 | 9.1 | IL1A, NGF, S100A8, JUN, FASLG, STAT5B | | 37 | positive regulation of NF-kappaB transcription factor activity | GO:051092 | 9.0 | NFKB1, TLR4, TNF, TLR2, ICAM1, IL6 | | 38 | immune response | GO:006955 | 9.0 | HAMP, CXCL9, CXCL2, CXCL1, IL1RAP, IL1A | | 39 | positive regulation of I-kappaB kinase/NF-kappaB cascade | GO:043123 | 8.9 | GJA1, S100A12, IL1B, TLR9, REL, RELA | | 40 | response to mechanical stimulus | GO:009612 | 8.7 | JUN, CCL2, NGF, MMP9, CAV1, TNF | | 41 | MAPK cascade | GO:000165 | 8.6 | IL18, IL1B, EGFR, TNF, CAV1, CCL2 | | 42 | anti-apoptosis | GO:006916 | 8.4 | THBS1, RELA, MYD88, NFKB1, IL1A, IL1B | | 43 | angiogenesis | GO:001525 | 8.2 | JUN, MMP2, VEGFA, ROBO4, CCL2, EGF | | 44 | inflammatory response | GO:006954 | 7.7 | IL17A, CCL20, IFNA2, AIMP1, TNF, DARC | | 45 | negative regulation of cell proliferation | GO:008285 | 7.7 | IL6, FGF2, JUN, VDR, IL1A, GJA1 | | 46 | response to drug | GO:042493 | 7.6 | MMP9, THBS1, JUN, CCL2, FAS, TSPO | | 47 | signal transduction | GO:007165 | 7.6 | FAS, IL1B, FASLG, FGF2, CD4, IL8 | | 48 | response to hypoxia | GO:001666 | 7.5 | MMP9, IL18, IL1A, IL1B, FAS, CCL2 | | 49 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | 7.1 | JUN, TLR4, NFKB1, MYD88, PAX6, TLR2 | | 50 | organ morphogenesis | GO:009887 | INF | , COL9A1, TNF, FGF2, PAX6, CCL2 |
Molecular functions related to keratitis according to GeneDecks: (show all 10)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | chemokine activity | GO:008009 | 9.9 | CXCL9, CXCL2, CXCL1, CCL20, CCL2, IL8 | | 2 | receptor activity | GO:004872 | 9.8 | ROBO4, TLR8, TLR4, TLR2, DARC, ICAM1 | | 3 | transmembrane signaling receptor activity | GO:004888 | 9.8 | TLR4, TLR2, TLR10, EGFR, DARC, ICAM1 | | 4 | receptor binding | GO:005102 | 9.7 | TNFSF4, HLA-B, GJA1, CAV1, CCL2, MBL2 | | 5 | cell surface binding | GO:043498 | 9.6 | AIMP1, HSPD1, ICAM1, MIF, VEGFA | | 6 | double-stranded DNA binding | GO:003690 | 9.1 | STAT5B, STAT1, EGFR, NFKB1, JDP2, JUN | | 7 | tumor necrosis factor receptor binding | GO:005164 | 9.0 | STAT1, TNFSF4, TNF, FASLG | | 8 | growth factor activity | GO:008083 | 8.8 | CXCL1, HBEGF, EGF, NGF, IL6, IL1B | | 9 | cytokine activity | GO:005125 | 7.8 | FASLG, IFNA2, AIMP1, TNF, TNFSF4, CXCL9 | | 10 | protein binding | GO:005515 | INF | GDI1, KRT16, NFKB1, SRCIN1, PTPRJ, TNF |
|